ARKgen BioScions

BiotechnologySeries ADaejeon, South Koreaarkgenbio.com

Latest round

Series A

Last raised

Jul 2026

Total raised

$6.6M

Investors

12

About ARKgen BioScions

Based in Seoul, South Korea, and founded in 2021, ARKgen BioScions Inc. operates as a biopharmaceutical company that develops immuno-anticancer drugs using a multi-antibody platform. In July 2026, ARKgen BioScions Inc. ARKgen BioScions Inc. offers a pipeline of products that provides solutions for previously challenging medical indications. The company specializes in developing advanced solutions that harness the power of genetic research, bioinformatics, and molecular biology. These solutions cater to a diverse range of applications, from drug discovery and development to precision medicine and agricultural biotechnology.

Who invested in ARKgen BioScions

12 investors across 2 rounds

See all investors in ARKgen BioScions

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jul 13, 2026

    Amount

    $6.6M

    Investors

    Locked

  2. Seed

    Dec 26, 2023

    Amount

    Undisclosed

    Investors

    Locked

Questions about ARKgen BioScions

Who invested in ARKgen BioScions?

ARKgen BioScions has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has ARKgen BioScions raised?

ARKgen BioScions has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did ARKgen BioScions last raise money?

ARKgen BioScions's most recent round on record is a Series A, in Jul 2026.

What does ARKgen BioScions do?

Based in Seoul, South Korea, and founded in 2021, ARKgen BioScions Inc.

Where is ARKgen BioScions headquartered?

ARKgen BioScions is headquartered in Daejeon, South Korea.

Which VCs invest in companies like ARKgen BioScions?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at ARKgen BioScions's stage. Their profiles are linked below.

Raising like ARKgen BioScions? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.